Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gabor Toth

Vascular Neurology Cleveland, OH Medical Doctor

NPI 1104014083 CMS profile 4853

9500 Euclid Ave, Mail Code S80, Cleveland, OH 44195

Open in the dashboard

General payments

$34,370

105 records reported · program years 2019–2025

Research payments

$41,400

Paid to them · 56 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$526,223 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Gabor Toth of Cleveland, OH is reported in the CMS Open Payments database as having received $34,370 across 105 general payments and $41,400 in research payments paid to them. Separately, studies naming them as principal investigator received $526,223 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Vascular Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

14 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $13,049 21
2025 Research $3,300 6
2024 General $8,713 22
2024 Research $9,000 12
2023 General $2,541 21
2023 Research $9,900 12
2022 General $667 9
2022 Research $10,900 12
2021 General $633 6
2021 Research $6,500 9
2020 General $4,897 8
2020 Research $300 1
2019 General $3,869 18
2019 Research $1,500 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gabor Toth
  • Vascular Neurology median
  • Middle half of Vascular Neurology
  • National median

In program year 2025, general payments to Gabor Toth were reported at $13,049. Among 416 Vascular Neurology profiles paid that year, the median was $360 and the middle half received between $91 and $1,472.

Show as a table
Year Gabor Toth Vascular Neurology median Middle half National median
2019 $3,869 $263 $102–$1,640 $163
2020 $4,897 $153 $45–$1,000 $114
2021 $633 $261 $100–$1,355 $132
2022 $667 $242 $87–$1,273 $149
2023 $2,541 $322 $97–$1,266 $160
2024 $8,713 $247 $70–$1,053 $164
2025 $13,049 $360 $91–$1,472 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Penumbra, Inc. $18,373 25 payments
  2. MicroVention, Inc. $11,365 36 payments
  3. Medtronic, Inc. $3,291 31 payments
  4. Stryker Corporation $516 4 payments
  5. DePuy Synthes Sales Inc. $339 3 payments
  6. Route 92 Medical, Inc. $243 2 payments
  7. Biosense Webster, Inc. $139 2 payments
  8. Medtronic USA, Inc. $105 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $17,950 6 payments
  2. Travel and Lodging $10,612 42 payments
  3. Food and Beverage $4,657 55 payments
  4. Education $850 1 payment
  5. Consulting Fee $300 1 payment
Products named General payments · program years 2019–2025
  1. Penumbra System $17,679 19 payments
  2. SOFIA $4,980 10 payments
  3. Pipeline $2,867 24 payments
  4. WEB ANEURYSM EMBOLIZATION SYSTEM $1,844 8 payments
  5. SOFIA 6F-131CM STR $1,532 4 payments
  6. CHAPERON GUIDING CATHETER $1,532 4 payments
  7. Azur CX Detachable $1,485 4 payments
  8. STENT Neurological Product $1,483 4 payments
  9. WEB $797 6 payments
  10. STENT Neurological Product $522 7 payments
  11. Other $3,735 41 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $39,600 51 payments
  2. Medtronic USA, Inc. $1,800 5 payments

Billing to Medicare

Part B · data year 2024 · 35 billing codes

Paid by Medicare

$53,691

Medicare's payments for the services billed

Medicare patients

117

Average age 74

Services billed

346

70 women, 47 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 43%
Ischemic heart disease 38%
Diabetes 32%
Atrial fibrillation 30%
Depression 28%
Heart failure 24%
COPD 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

161 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Neurology in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record